The use of biologically active compounds has become a realistic option for the treatment of malignant tumors due to their cost-effectiveness and safety. In this review, we aimed to …
L Al-Ali, RJ Al-Ani, MM Saleh, AM Hammad… - Saudi Pharmaceutical …, 2024 - Elsevier
Background The use of tyrosine kinase inhibitors (TKIs) as a treatment for chronic myeloid leukemia (CML) has improved the natural history of the disease and increased the duration …
Y Zhang, QU Yong, C Yun-Zhong - Chinese Journal of Natural Medicines, 2022 - Elsevier
Currently, chemoresistance seriously attenuates the curative outcome of liver cancer. The purpose of our work was to investigate the influence of 6-shogaol on the inhibition of 5 …
A Golestani, A Rahimi, M Najafzadeh, M Sayadi… - Molecular Biology …, 2024 - Springer
Background Imatinib resistance remains a major obstacle in the treatment of chronic myelogenous leukemia (CML). Crocin (CRC) and astaxanthin (ATX) are phytochemicals …
C Yang, W Chen, B Ye, K Nie - Food & Function, 2024 - pubs.rsc.org
Ginger (Zingiber officinale Roscoe) has traditionally been used as a cooking spice and herbal medicine for treating nausea and vomiting. More recently, ginger was found to …
F Doganc, T Ozkan, N Farhangzad, A Mavideniz… - Bioorganic …, 2024 - Elsevier
Cannabinoids bind to cannabinoid receptors CB1 and CB2 and their antitumoral activity has been reported against some various cancer cell lines. Some synthetic cannabinoids …
GK Marioli-Sapsakou, M Kourti - Anticancer Research, 2021 - ar.iiarjournals.org
Cancer remains the second leading cause of death worldwide. Research is currently focused on finding novel anticancer therapies and elucidating their mechanisms of action …
ZG Sun, CJ Yao, I Ullah, HL Zhu - Mini Reviews in Medicinal …, 2024 - ingentaconnect.com
Leukemia and lymphoma are the most common blood cancers, which pose a critical threat to the health of adults and children. The total incidence and mortality rates of both are …
AZ Karabay, T Ozkan, A Karadag Gurel, A Koc… - Naunyn-Schmiedeberg's …, 2024 - Springer
Chemotherapy resistance is a major obstacle in cancer therapy, and identifying novel druggable targets to reverse this phenomenon is essential. The exosome-mediated …